Program

PART ONE

Theme: From Concepts to Markets
Time: October 28-30, Shanghai, China Venue: Shanghai Worldfield Convention Center
 

Day One Morning £¨ October 28th ) Opening Ceremony

Opening Ceremony and Nobel Laureate Forum
(Place: Auditorium, Convention Centre Level 3, Worldfield Convention Hotel)
09:00-09:45 Opening Ceremony
VIP Speeches
09:45-10:00 Coffee Break
10:00-11:30 Shanghai Nobel Laureate Forum
10:00-10:45 Title: The Secret Life of Enzymes: An Aggressive Strategy for Drug Discovery
Dr. K. Barry Sharpless, The Nobel Prize in Chemistry, 2001
10:45-11:30 Title: Electron Transfer Reactions in Chemistry and Biology ¨C Then and Now
Dr. Rudolph A. Marcus, The Nobel Prize in Chemistry, 1992
12:00-13:00 Luncheon and Showcases

Day One Afternoon £¨ October 28th) Parallel Symposia (Session 1-3) and Workshops

Session One: New technology and new model for human disease and drug discovery
(Place: SHANGHAI RM 6, Convention Centre Level 3, Worldfield Convention Hotel)
Session Chair: Dr. R. A. Marcus, The Nobel Prize in Chemistry, 1992
Co-Chair: Dr. Su Guo, Deaprtment of Biopharmaceutical Sciences, Programs in Human Genetics and Biological Sciences, University of California San Francisco, USA University of California, San Francisco, USA
13:30-13:55 Title: Protein/ Ligand Interactions in the Green Fluorescent Protein and its Analogs, or Protein/Legend Interactions in Flavoproteins
Dr. M. E. Michel-Beyerle, The Physical Chemistry Laboratory of the Technical University of Munich, Germany
13:55-14:20 Title: ANTICALINS: Small Antibody-like Binding proteins for Biopharmaceutical Drug Development
Dr. Arne Skerra, Biological Chemistry Laboratory of the Technical University of Munich, Germany
14:20-14:45 Title: The Zebrafish¡ªDisruptive Technology for Drug Discovery
Dr. Randall T. Peterson, Assistant Professor of Medicine, Harvard Medical School, Massachusetts General Hospital
14:45-15:10 Title: Cardiovascular development and regeneration
Dr. Tao Peter. Zhong, Vanderbilt University School of Medicine, USA
15:10-15:25 Coffee Break
15:25-15:50 Title: Dopamine Neuron Regeneration, Parkinson¡¯s Disease, and Addiction: from Mechanisms to Drug Discovery
Dr. Su Guo, Deaprtment of Biopharmaceutical Sciences, Programs in Human Genetics and Biological Sciences, University of California San Francisco, USA University of California, San Francisco, USA
15:50-16:15 Title: Towards Genetic Medicine: Zebrafish as an Animal Model for Cardiomyopathy
Dr. Xiaolei Xu, Division of Cardiovascular Diseases/Department of Biochemistry and Molecular Biology, Mayo Clinic, USA
16:15-16:40 Title: Visualizing Neuronal Loss in Zebrafish
Dr. Weimin Xia, Center for Neurologic Diseases, Brigham and Women's hospital, Harvard Institute of Medicine, Boston, MA, USA


Session Two: Functional Genomics: Proteomics Technology and System Biology
(Place: SHANGHAI RM 4, Convention Centre Level 3, Worldfield Convention Hotel)
Session Chair: Dr. Chung Hsuan Chen, Division Director, Research Fellow & Key technology Leader, Consultant, Oak Ridge National Laboratory, The Genomics Research Center, Academia Sinica, Taiwan, China
Co-Chair: Dr. Samir N. Khleif, Chief, Cancer Vaccine Section, National Cancer Institute, USA and Director General/CEO, King Hussein Cancer Center, Jordan
13:30-13:55 Title: Effects of Eisenia Fetida Protease-III-1 and Protease-II on Fibrinolysis and Thrombosis System
Dr. Rong-Qiao He, Professor, State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Science, China
13:55-14:20 Title: Remarkable Application of SELDI-TOF-MS Technology in Proteomic Research
Dr. Chi-Shing Cho, Scientific Officer, Queen Elizabeth Hospital, Hong Kong, China
14:20-14:45 Title: Novel Mass Spectrometry for Disease Diagnosis
Dr. Chung Hsuan Chen, Division Director, Research Fellow & Key technology Leader, Consultant, Oak Ridge National Laboratory, The Genomics Research Center, Academia Sinica, Taiwan, China
14:45-15:10 Title:Cancer Vaccines
Dr. Samir N. Khleif, Cancer Vaccine Section, National Cancer Institute, USA and Director General/CEO, King Hussein Cancer Center, Jordan
15:10-15:25 Cofee Break
15:25-15:50 Title: Dipeptidyl Peptidase IV as a Molecular Target for Novel Therapeutic Strategy of Diabetes Mellitus
Dr. Hua Fan, Profssor, Institute of Molecular Biology and Biochemistry, Free University Berlin, Germany
15:50-16:15 Title: Redesign of Aminoglycoside Antibiotics: From Effective Treatment of Anthrax to Antibiotics Targeting Cystic Fibrosis
Dr. Timor Baasov, Department of Chemistry and Institute of Catalysis Science and Technology, Israel
16:15-16:40 Title: Basic fibroblast Growth Factor (bFGF) and Its Application in Wound Healing
Prof. Xiaokun Li, School of Pharmaceutical Sciences, Wenzhou Medical Collage, Wenzhou China


Session Three: RNAi, siRNA Technologies in Drug Discovery
(Place: SHANGHAI RM 5, Convention Centre Level 3, Worldfield Convention Hotel)
Session Chair: Dr. Dmitry Samarsky, Director of Technology Development, Dharmacon Inc., USA
Co-Chair:
Dr. Xingwang Fang, Senior Scientist, Ambion Inc, USA
13:30-14:00 Title: MicroRNA and Human Diseases
Dr. Xingwang Fang, Senior Scientist , Ambion, Inc, USA
14:00-14:30 Title: siRNA On and Off target: siRNA Non- specific Activities in HTS Screening and Therapeutic Development
Dr. Dmitry Samarsky, Director of Technology Development, Dharmacon Inc., USA
14:30-15:00 Title: Understanding Molecular Mechanisms of Pre-mRNA and Developing New Therapies for Neurodegeneration Based on Regulating Splicing
Dr. Jane Wu, Charles Louis Mix Professor of Neurology, Northwestern University Medical School, USA
15:00-15:15 Coffee Break
15:15-15:45 Title: A new Inducible RNAi Model for Cancer Target Validation In vivo Q-X Li, N Ke
Dr. Flossie Wong-Staal, Professor Emeritus, Member, Institute of Medicine, US; Academia Sinica, Taiwan, Chief Scientific Officer and Executive Vice President of Research, Immusol, Inc., USA
15:45-16:15 Title: Clinical Trials of Gene Therapy Using anti-HIV RNA
Dr. Shirley Li, Core Director of antiviral Research Laboratory, Division of Virology, City of Hope National Medical Center, Beckman Research Institute, USA
16:15-16:45 Title: Harnessing RNAi As a Novel Gene Therapy for Virus Infection: Targets and Delivery
Dr. Erwei Song, Dept of Surgery, Sun-Yat-Sen Memorial Hospital, China

Day Two Morning £¨ October 29th £© Parallel Symposia (Session 4-6) and Workshops

Session Four: Target Evaluation and Validation
(Place: SHANGHAI RM 6, Convention Centre Level 3, Worldfield Convention Hotel)
Session Chair: Dr. Colin Collins, Associate Professor, University of California, San Francisco Comprehensive Cancer Center, USA
Co-Chair:
Dr. Bin Liu, Assistant Professor, Department of Anesthesia, UCSF Comprehensive Cancer Center, USA
08:30-08:55 Title: Comparison of Display Technologies for Making Therapeutic Antibodies
Dr. Bin Liu, Assistant Professor, Department of Anesthesia, UCSF Comprehensive Cancer Center, USA
08:55-09:20 Title: Toward A Suite Of Biomarkers and Drug Targets For Prostate Cancer
Dr. Colin Collins, Associate Professor, University of California, San Francisco Comprehensive Cancer Center, USA
09:20-09:45 Title: Two Faces of the Receptor Associated Protein ¨C the Mechanism that Mediates its Interaction with the LRP receptor
Dr. Yun-Xing Wang, PNAI, Structural Biophysics Lab, National Cancer Institute, National Institutes of Health, USA
09:45-10:10 Coffee Break
10:10-10:25 Title: Modification of Eukaryotic Initiation Factor 5A From Plasmodium ViVax by Deoxyhypusine Synthase from Plasmodium Flaciparum
Dr. Annette Kaiser, Professor, Biology Department, German University in Cairo, Egypt
10:25-10:50 Title: Neuroregeneration/Neuroprotection in MS: MRI Evidence
Dr. Joseph Frank, Chief, Experimental Neuroimaging Section, Laboratory of Diagnostic Radiology Research Clinical Center National Institutes of Health Building, USA
10:50-11:15 Title: A new method used for cloning and expression of Brucella antigens
Dr. Tom Ding, Department of Bacterial Diseases, Division of communicable Diseases and Immunology, Walter Reed Army Institute of Research, USA
11:15-11:40 Title: Anti-CD146 monoclonal antibody as cancer therapy
Dr. Le Sun, CEO/President, Welson Oharmaceuticals Inc, USA

Session Five: Major Diseases, Cancer and Tumour/Alzheimer/ Cardiovascular
(Place: SHANGHAI RM 5, Convention Centre Level 3, Worldfield Convention Hotel)
Session Chair: Dr. Wassil Nowicky, Director of "Nowicky Pharma" and President of The Ukrainian Anti-Cancer Institute, Austria
Co-Chair:
Dr. Weibin Shi, Associate Professor, University of Virginia, Radiology/Cardiovascular Research Center, USA
08:30-08:50 Title: Herbal medicinal product on the basis of Chelidonium majus L. NSC-631570
Dr. Wassil Nowicky, Director of "Nowicky Pharma" and President of The Ukrainian Anti-Cancer Institute, Austria
08:50-09:10 Title: Activity-based drug discovery generates a novel non-estrogenic, anti-fibrotic analogue of 2-methoxyestradiol, CP2117
Dr. Alastair George Stewart, CEO, Cryptopharma, Melbourne University Private, Australia
09:10-09:30 Title: BACE Inhibitors: Progression from Statine-based Analogs to Cell Permeable
Dr. Jingdan Hu, Eli Lilly and Company, USA
09:30-09:40 Coffee Break
09:40-10:00 Title: Modern Development of Novel Therapy for Brain Tumor
Dr. Lan Huang, Chief Scientific Officer (CSO), HYWE Pharmaceuticals Inc., USA
10:00-10:20 Title: Cellular and Genetic Control of Atherosclerosis Susceptibility.
Dr. Weibin Shi, Associate Professor, University of Virginia, Radiology/Cardiovascular Research Center, USA
10:20-10:40 Title: Potent PPAR-agonists: Global Efforts to Manage Dyslipidemia
Dr. Debnath Bhuniya, Research Director, Metabolic Disorder Group (Medicinal Chemistry), Dr. Reddy's Laboratories Ltd.- Discovery Research SBU, India
10:40-11:00 Title: Ukrain (NSC-631570) in the Treatment of Gastrointestinal Cancers
Dr. Olga Prokopchuk, Assistant Professor, Department of Internal Medicine II, Ulm University Clinic, Germany
11:00-11:20 Title: Nicotiflorin reduces cerebral ischemic damage and upregulates endothelial nitric oxide synthase in primary cultured rat cerebral blood vessel endothelial cells and protects neurons in neuronal cultures
Dr. Meili Guo, Associate Professor, School of Pharmacy, Second Military Medical University, China
11:20-11:40 Title: A Recombinant P16-Adenovirus (rAd-P16) as Gene Therapy for Nasopharyngeal Carcinoma
Dr. Jingzhong Lin, CEO, Shenzhen Taitai Genomics, Inc., Shenzhen, China

Session Six: Signaling Transduction Pathway as Target in Drug Discovery
(Place: SHANGHAI RM 4, Convention Centre Level 3, Worldfield Convention Hotel)
Session Chair: Dr. Piyush C. Kothary, Sr. Res. Associate, University of Michigan, USA
08:30-09:00 Title: The Role of MAP Kinases and Phosphatases in Cell Signaling and Autoimmunity
Dr. Tse-Hua Tan, Professor, Department of Immunology, Baylor College of Medicine, USA
09:00-09:30 Title: Wnt Signaling in Lung Cancer
Dr. Biao He, Assistant Professor, Cancer Center, University of California, San Francisco, USA
09:30-10:00 Title: ERK-Pathway Inhibitor
Dr. Piyush C. Kothary, Sr. Res. Associate, University of Michigan, USA
10:00-10:15 Coffee Break
10:15-10:45 Title: Creating New Effective and Safe Medicines Based on Computer-Aided Predicting of Biological Activity Spectra
Dr. Vladimir Poroikov, Vice-Director (Research), Head of Laboratory for Structure-Function Based Drug Design, Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Russia
10:45-11:15 Title: Design of a Novel Cathepsin-K Inhibitor: A Computational Approach
Dr. Wu Ping, Senior Scientist, Senior Scientist and Senior Program Manager, Institute of High Performance Computing, Singapore
11:15-11:45 Title: Toward the Design of Rotavirus-specific Therapeutics
Dr. Helen Blanchard, Research Leader, Institute for Glycomics, Griffith University (Gold Coast Campus), Australia

12:00-13:00 Luncheon and Showcases

Day Two Afternoon £¨ October 29th £© Parallel Symposia (Session 7-9) and Workshops

Session Seven: Immunotherapy and Therapeutic Vaccines
(Place: SHANGHAI RM 5, Convention Centre Level 3, Worldfield Convention Hotel)
Session Chair: Dr. Julianna Lisziewicz, President, Genetic Immunity, LLC, USA
Co-Chair: Dr. Brian Wong, MD PhD, Director, Inflammation, Autoimmunity & Transplantation Research Roche Palo Alto

13:30-13:55 Title:The Development of Drugs that Inhibit Critical Protein Targets That control the Immune Response
Dr. Brian Wong, MD PhD, Director, Inflammation, Autoimmunity & Transplantation Research Roche Palo Alto
13:55-14:20 Title: Dermavir: Dendritic Cell-Based Topical Immunization For The Treatment of HIV/AIDS
Dr. Julianna Lisziewicz, President, Genetic Immunity, LLC, USA
14:20-14:45 Title: Quantitative Evaluation of the Therapeutic Effects of Antibiotics Using Silkworms Infected with Human Pathogenic Microorganisms, S. aureus and True Fungi
Dr. Kazuhisa Sekimizu, Department of Pharmacology£¬Faculty of Medicine£¬University of Tokyo, Japan
14:45-15:00 Coffee Break
15:00-15:25 Title: Catalytic Vaccines
Dr. Alexander Gabibov, Member of Russian Academy of Sciences, lab of biocatalysis, IBCH RAS, Professor of the Moscow State University, Russia
15:25-15:50 Title: Virostatics: A New Family of Antiretroviral Drugs Acting by Immune System Modulation
Dr. Franco Lori, Scientific Director, RIGHT ¨C Research Institute for Genetic and Human Therapy, Italy
15:50-16:15 Title: Bacterial Peptides with Antimicrobic and Immunomodulatihngaction
Dr. Alexis Egorov, Professor, National Research Centre for Antibiotics, Russia
16:15-16:40 Title: Application of Peptide Arrays and Peptides Generated by Computer
Dr. William Jia, Associate Professor, University of British Columbia, Vanvouver, Canada

Session Eight: Predictive Pharmacology/ADMET in New Drug Development
(Place: SHANGHAI RM 6, Convention Centre Level 3, Worldfield Convention Hotel)
Session Chair: Dr. Zhuohan Hu, Research Institute for Liver Diseases (Shanghai) Co. Ltd., China
13:30-14:05 Title: Using Computer Knowledge-based Systems to Predict Metabolism and Toxicity
Dr. Philip Judson, Department of Chemistry, University of Leeds, UK
14:05-14:40 Title: Tibet Wilding Plant Resource Investigation & New Medicine Discovery
Dr. Baosong Cai, Vice Director, University of Jiaotong, Shanghai, China
14:40-15:15 Title: Building Intrinsic Quality Into a Molecule: Key Questions and Technologies in ADMET
Dr. Hequn Yin, Novartis Pharmaceuticals Corp. USA
15:15-15:30 Coffee Break
15:30-16:05 Title: Application of in Vitro Models in Evaluating ADMET of Innovative Therapeutics
Dr. Zhuohan Hu, Research Institute for Liver Diseases (Shanghai) Co. Ltd., China
16:05-16:40 Title: Application Of GastroPlus In Simulating GI Absorption And Pharmacokinetics For Orally Dosed
Dr. Chun-Lin Chen, Shanghai Medicilon Inc. China

Session Nine: Drug Delivery Technology
(Place: SHANGHAI RM 4, Convention Centre Level 3, Worldfield Convention Hotel)
Session Chair: Dr. Gabriele Betz, Institute of Pharmaceutical Technology, Industrial Pharmacy Lab, University of Basel, Switzerland
Co-Chair: Dr. Longping Wen
, Professor of Molecular & Cell Biology, School of Life Science, University of Science & Technology of China
13:30-14:00 Title: Transdermal Drug Delivery By A Co-administered Peptide Identified Through In Vivo Phage Display
Dr. Longping Wen, Professor of Molecular & Cell Biology, School of Life Science, University of Science & Technology of China
14:00-14:30 Title: Nano-composites by Atmospheric Spray-freeze Drying as Carriers for Thermo Sensitive and How Water Soluble Drugs
Dr. Gabriele Betz, Institute of Pharmaceutical Technology, Industrial Pharmacy Lab, University of Basel, Switzerland
14:30-15:00 Title: Sustained-release of Protein Drugs: Challenges and Solutions
Dr. Tuo Jin, School of Pharmacy, Jiaotong University, Shanghai, China
15:00-15:15 Coffee Break
15:15-15:45 Title: Tumor-targeting with Albumin-drug Conjugates
Dr. Yuqiang Wang, Institute of New Drug Research, Jinan University School of Pharmaceutical Sciences, Guangzhou, China
15:45-16:15 Title: Nano-composites by Atmospheric Spray-freeze Drying as Carriers for Therosensitive and Low Water Soluble Drugs
Dr. Menshutina Natalia, Mendeleyev University of Chemical Technology of Russia, Moscow, Russia

PART TWO

Theme: The Increasing Impacts of Modern Chemistry on Drug Discovery
Time: October 31-November 1, Dalian, China Venue: Dalian Furama Hotel or Dalian Institute of Chemical Physics, CAS

Day One Morning £¨ October 31th £© Opening Ceremony

Opening Ceremony and Nobel Laureate Forum
(Place: Grand Ballroom, 2/F, Furama Hotel)
09:00-09:45 Opening Ceremony
VIP Speeches
09:45-10:00 Coffee Break
10:00-11:30 Dalian Nobel Laureate Forum
10:00-10:45 Title: Stitching with Nitrogen
Dr. K. Barry Sharpless, The Nobel Prize in Chemistry, 2001
10:45-11:30 Title: Electron transfers in nanoparticles and biological systems
Dr. Rudolph A. Marcus, The Nobel Prize in Chemistry, 1992
12:00-13:00 Luncheon and Showcases

Day One Afternoon £¨ October 31st £© Parallel Symposia (Session 10-11) and Workshops

Session Ten: Structure Based Drug Design
(Place: Tian Bo Fu Ballroom C, 2/F, East Wing, Furama Hotel)
Session Chair: Dr. Michael Hennig, Vice Director, F. Hoffmann-La Roche Ltd., Pharma Research Basel Discovery, Section Head, Molecular Structure Research, Switzerland
13:30-14:05 Title: A New Paradigm in Structure Based Drug Discovery
Dr. Michael Hennig, Vice Director, F. Hoffmann-La Roche Ltd., Pharma Research Basel Discovery, Section Head, Molecular Structure Research, Switzerland
14:05-14:40 Title: Design and Synthesis of Sulfonamide-based Bradykinin B1 Receptor Antagonists for the Treatment of Pain and Inflammation
Dr. Jeff Chen, Principal Scientist, CR&D, Amgen Inc., CA, USA
14:40-14:55 Coffee Break
14:55-15:30 Title: Structure-based Design of Novel Tat Inhibitors With Increased Specificity And Enhanced Pharmacological Potential
Dr. Z. Athanassiou, University of Washington, USA
15:30-16:05 Title: Structural Studies on Urokinase and Urokinase Receptor: A Target System for Anti-tumor Metastasis
Dr. Mingdong Huang, Researcher, State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences

Session Eleven: From Peptidomimetics to Small Molecule Drug Discovery
(Place: Grand Ballroom, 2/F, Furama Hotel)
Session Chair: Dr. Gyorgy Keri, Peptide Biochemistry Res. Group of Hung. Acad. Sci., Department of Medical Chemistry Semmelweis University, Hungary
Co-Chair: Dr. Jack Lai, Professor, Department of Chemistry, University of Tufits, USA
13:30-14:00 Title: Signal Transduction Therapy with Antitumor Peptides and Peptidomimetics
Dr. Gyorgy Keri, Peptide Biochemistry Res. Group of Hung. Acad. Sci., Department of Medical Chemistry Semmelweis University, Hungary
14:00-14:30 Title: Synthesis and Structural Investigation of Internally Coordinated Alpha-Aminoboronic Acids
Dr. Jack Lai, Professor, Department of Chemistry, University of Tufits, USA
14:30-15:00 Title: Isolation and Structure of Ternatin, an Inhibitory Effect of Fat Accumulation from the Mushroom Coriolus Versicolor
Dr. Daisuke Uemura, Professor, Department of Chemistry, Graduate School of Science, Nagoya University, Japan
15:00-15:15 Coffee Break
15:15-15:45 Title: Physiological Role of Compatible Solute Ectoine and the Potential Application
Dr. Yaobing Wang, Researcher, National Marine Environmental Monitoring Center, China
15:45-16:15 Title: Explore the Effect and Possible Mechanism of Anti-cancer Bioactive Peptide (ACBP) for the Orthotopic Transplantation Hepatocellular Carcinoma In Nude Mice
Prof. Xiulan Su, Molecular biology center Huhhaot, Inner Mengolia Medical College, China
16:15-16:45 Title: Oriented Teatment of Tpe B Hpatitis by Ativated Dndritic Clls
Prof. Xiaojun Yan, Institute of Genetic Diagnosis, the Fourth Military Medical University,China

Day Two Morning £¨ November 1st £© Parallel Symposia (Session 12-13) and Workshops

Session Twelve: Modern Synthetic Organic Chemistry for Drug Synthesis and Catalytic Asymmetric Synthesis in Chiral Drugs
(Place: Grand Ballroom, 2/F, Furama Hotel)
Session Chair: Dr. Konrad H. Bleicher F., Hoffmann-La Roche, Basel
Co-Chair: Dr. Jih Ru Hwu, Professor of National Tsing Hua University, Taiwan, China
08:30-09:05 Title: Chemo-combination Strategy on the Development of New Drugs and Novel Nano Magic Bullets
Dr. Jih Ru Hwu, Professor of National Tsing Hua University, Taiwan, China
09:05-09:40 Title: Hit&Lead Generation Beyond HTS
Dr. Konrad H. Bleicher F., Hoffmann-La Roche, Basel, Switzerland
09:40-10:15 Title: Chiral N-salicylidene Vanadyl complexes-Catalyzed Enantioselective Aerobic Oxidation of alpha-Hydroxy Esters and Amides
Dr. Chien Tien Chen, Professor, National Taiwan Normal University, Taiwan, China
10:15-10:30 Coffee Break
10:30-11:05 Title: The Strategy of Chiral Switches of Drugs: Recent Developments
Dr. Israel Agranat, Professor of Organic Chemistry, The Hebrew University of Jerusalem, Israel

Session Thirteen: New Biopharmaceutical Products: Application of Large-scale mammalian cell in Drug Discovery

(Place: Tian Bo Fu Ballroom C, 2/F, East Wing, Furama Hotel)
08:30-09:10 Title: Use of Functional Fusion Partners to Extend Existing Protein/antibody Therapeutics for Bi-specific Neutralizing and Disease Site Delivery: A Modified Generic Drug Development Strategy
Dr. Matthew Hui, Chief Scientist and team coordinator, AmProtein Corporation, California, USA
09:10-09:50 Title: Large-scale Mammalian Cell Culture Platform in China: Cell lines, Suspension Serum-free Media, and Mammalian Bioreactors
Dr. Matthew Hui, Chief Scientist and team coordinator, AmProtein Corporation, California, USA
09:50-10:30 Title: Current Therapeutic Antibody Production Process and Optimization
Dr. Feng Li, Amgen Inc., Thousand Oaks, CA, USA
10:30-11:10 Title: Advance of the Bioreactor Equipment Manufactures in China
Dr. Siliang Zhang, State Key Laboratory of Bioreactor Engineering, National Engineering Centre for Biotechnology, Shanghai, China

12:00-13:00 Luncheon and Showcases

Day Two Afternoon £¨ November 1st £© Parallel Symposia (Session 14-15) and Workshops

Session Fourteen: Clinical Trials and Clinical Drug Candidate Outsourcing
(Place: Tian Bo Fu Ballroom C, 2/F, East Wing, Furama Hotel)
Session Chair: Dr. Apurba Bhattacharya, Professor, Department of Chemistry , Texas A&M University Kingsville, USA
13:30-13:55 Title: Antibiotics May Act as Growth/obesity Promoters in Humans?
Dr. Gabor Ternak, Head of the Dept. of Infectology, University of Pecs, Hungary
13:55-14:20 Title: Archive Management in GLP Laboratory
Prof. Aiping Wang, New Drug Safety Evaluation Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
14:45-15:00 Coffee Break

Session Fifteen: Green Chemistry in Pharmaceutical Process and Increasing Drug Discovery Efficiency
(Place: Tian Bo Fu Ballroom C, 2/F, East Wing, Furama Hotel)
14:20-14:45 Title: Modern Analytical Chemistry and Biomedical Technologies in Drug Discovery
Dr. Gong Yinhan, Department of chemistry, National University of Singapore

_________________________________________________________________________________________________
For further information, please contact:

Ms. Annie Sun
Email: annie@whts.org
Tel: 86-411-84799609/84799639
Fax: 86-411-84799606